... with the cisplatin and doxorubicin regimen. The superior regimen (doxorubicin, cisplatin, and paclitaxel with G-CSF) was associated with 12% grade 3 and 27% grade 2 peripheral neuropathy. Given the toxicity and ... efficacy of these regimens, other treatment options have been widely sought. Several ...

... to the standard regimen, carboplatin plus pegylated liposomal doxorubicin is an important option for patients with platinum-sensitive recurrence. Carboplatin plus paclitaxel has been considered the standard regimen for platinum-sensitive recurrence in the absence of ...

... GD, et al.: Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. ...

... with either epirubicin and cisplatin, etoposide and leucovorin, doxorubicin and methotrexate, leucovorin and irinotecan, or docetaxel and cisplatin or oxaliplatin.[ 1 - 7 ] Doublet regimens. A taxane (docetaxel or paclitaxel) and either cisplatin or carboplatin. 5-FU and ...

... PubMed : 22897883 ] Han KS, et al. Methotrexate, vinblastine, ... et al. Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced ...

... and vinblastine; carboplatin, epirubicin, methotrexate, and vinblastine; and ... the MVAC regimen demonstrated improved response rate and longer median survival ( ...

... incurable locally advanced or metastatic bladder cancer? Comparison: Paclitaxel & ... for second-line chemotherapy (more...) Table ...

... modality for patients with inoperable thymic carcinoma. Most regimens used are similar to those used to treat thymoma and ... (chemotherapy): A phase II ...

... contains the following:[ 1 , 4 - 7 ] Methotrexate, vinblastine, ... However, the impact of any of these regimens on survival is not known for any stage ...

... have received at least one prior platinum-based regimen, but not all five ... topotecan, oral letrozole, or oral tamoxifen).[ 8 ][ Level ...